SB 22

  • Wisconsin Senate Bill
  • 2019-2020 Regular Session
  • Introduced in Senate Feb 08, 2019
  • Senate
  • Assembly
  • Governor

Relating to: regulating the sale of prescription drugs below cost. (FE)

Abstract

Bill Sponsors (6)

Bernier

     
Primary

Risser

     
Primary

Jacque

     
Primary

L. Taylor

     
Primary

Votes


No votes to display

Actions


Apr 01, 2020

Senate

Failed to pass pursuant to Senate Joint Resolution 1

Mar 19, 2019

Senate

Senator Kooyenga added as a coauthor

Feb 15, 2019

Senate

Fiscal estimate received

Feb 08, 2019

Senate

Introduced by Senators Carpenter, Bernier, Feyen, Risser, Jacque and L. Taylor; cosponsored by Representatives Ott, Kolste, C. Taylor, Sinicki and Sargent

Senate

Read first time and referred to Committee on Economic Development, Commerce and Trade

Bill Text

Bill Text Versions Format
Bill Text HTML PDF

Related Documents

Document Format
2019 Assembly Bill 156 HTML
Wisconsin Ethics Commission information HTML
SB22 ROCP for Committee on Economic Development, Commerce and Trade HTML
Fiscal Estimates and Reports HTML

Sources

Data on Open States is updated periodically throughout the day from the official website of the Wisconsin State Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.